News & Events

Oct 05, 2017

IFM Therapeutics LLC Appoints William R. Roush as Executive Vice President of Chemistry

Aug 10, 2017

BioCentury Innovations, “The Flip-Side of Immunotherapy”

Aug 07, 2017

BioWorld, “BMS looks to ‘marry’ adaptive, innate immunity with $2.32B+ IFM buy”